EG12529A - A,a diaryl-b(tert-amino)propanols,processes for their preparation and pharmaceutical compositions containing them - Google Patents

A,a diaryl-b(tert-amino)propanols,processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
EG12529A
EG12529A EG111/76A EG11176A EG12529A EG 12529 A EG12529 A EG 12529A EG 111/76 A EG111/76 A EG 111/76A EG 11176 A EG11176 A EG 11176A EG 12529 A EG12529 A EG 12529A
Authority
EG
Egypt
Prior art keywords
propanols
diaryl
tert
amino
processes
Prior art date
Application number
EG111/76A
Original Assignee
Temmler Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temmler Ag filed Critical Temmler Ag
Application granted granted Critical
Publication of EG12529A publication Critical patent/EG12529A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EG111/76A 1975-02-26 1976-02-25 A,a diaryl-b(tert-amino)propanols,processes for their preparation and pharmaceutical compositions containing them EG12529A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2508203A DE2508203C2 (en) 1975-02-26 1975-02-26 Use of polysubstituted α, α-diphenyl-β- (tert-amino) propanols in saluretic therapy

Publications (1)

Publication Number Publication Date
EG12529A true EG12529A (en) 1979-12-31

Family

ID=5939810

Family Applications (1)

Application Number Title Priority Date Filing Date
EG111/76A EG12529A (en) 1975-02-26 1976-02-25 A,a diaryl-b(tert-amino)propanols,processes for their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
CS (1) CS194723B2 (en)
DE (1) DE2508203C2 (en)
EG (1) EG12529A (en)
FI (1) FI752082A (en)
HU (1) HU171369B (en)
IE (1) IE42439B1 (en)
LU (1) LU72953A1 (en)
MX (1) MX3548E (en)
NO (1) NO142908C (en)
NZ (1) NZ178112A (en)
PL (1) PL101806B1 (en)
RO (1) RO70352A (en)
SU (2) SU618035A3 (en)
YU (1) YU182575A (en)

Also Published As

Publication number Publication date
NO142908B (en) 1980-08-04
NZ178112A (en) 1978-04-28
LU72953A1 (en) 1976-02-04
HU171369B (en) 1977-12-28
NO142908C (en) 1980-11-12
IE42439B1 (en) 1980-08-13
MX3548E (en) 1981-02-19
DE2508203A1 (en) 1976-09-09
YU182575A (en) 1982-02-28
DE2508203C2 (en) 1984-03-01
SU618035A3 (en) 1978-07-30
IE42439L (en) 1976-08-26
NO752485L (en) 1976-08-27
PL101806B1 (en) 1979-02-28
SU614093A1 (en) 1978-07-05
RO70352A (en) 1982-02-26
FI752082A (en) 1976-08-27
CS194723B2 (en) 1979-12-31

Similar Documents

Publication Publication Date Title
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL50632A (en) Pyridinyl-2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
ZA786313B (en) 9-(w-heteroarylamino-alkylamino-erythromycines,their salts,processes for their preparation and pharmaceutical compositions containing them
GB1518444A (en) N-phenyl-imidazolidine derivatives processes for preparing them and pharmaceutical compositions containing them
IL50176A0 (en) Novel tetrahydroisoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL51074A (en) Isoquinolinium derivatives,their preparation and pharmaceutical compositions containing them
IL49359A0 (en) New erythromycin derivatives,their preparation and pharmaceutical compositions containing them
IL49911A0 (en) New 5-aroylpyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL50690A0 (en) Novel benzisothiazole derivatives,their preparation and pharmaceutical compositions containing them
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL49758A0 (en) Novel phenothiazine derivatives,their preparation and pharmaceutical compositions containing them
IL49125A0 (en) A novel antibiotic,its preparation and pharmaceutical compositions containing it
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
IL50355A (en) N-tetrahydrofurfuryl noroxymorphone derivatives,their preparation and pharmaceutical compositions containing them
IL49360A0 (en) New erythromycin derivatives,their preparation and pharmaceutical compositions containing them
IL50156A (en) N,n-bis-isoquinolinoalkylamine derivatives, their preparation and pharmaceutical compositions containing them
ZA793682B (en) New piperidylbenzimidazolinone derivatives,processes for their preparation and pharmaceutical compositions containing them
GB1552460A (en) Diphenylacetamide derivatives processes for their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
DE2861177D1 (en) 2-benzazepine compounds, processes for their preparation and pharmaceutical compositions containing them
IL49971A0 (en) New 2-benzoypranone derivatives,their preparation and pharmaceutical compositions containing them
EP0018077A3 (en) Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines
IL50399A (en) Substituted sulphoximides,a process for their preparation and pharmaceutical compositions containing these compounds